Abstract
RANTES (Regulated on activation, normal T-cell expressed and secreted), recruits circulating leukocytes and augments inflammatory responses in many clinical conditions. Inflammatory responses in ischemia-reperfusion injury (IRI) significantly affect the unfavorable outcomes of acute kidney injury (AKI) and that infiltrating immune cells are important mediators of AKI. However, the significance of RANTES in AKI and whether hypoxia-induced LncRNAs are involved in the regulatory process of AKI are not known. Here we show that, in the kidney IRI mice model, significant RANTES expression was observed in renal tubular cells of wild type mice. RANTES deficient (RANTES−/−) mice showed better renal function by reducing the acute tubular necrosis, serum creatinine levels, infiltration of inflammatory cells and cytokine expressions compared to wild type. In vitro, we found that RANTES expression was regulated by NF-κB. Further, renal tubular cells showed deregulated LncRNA expression under hypoxia. Among HIF-1α dependent LncRNAs, PRINS (Psoriasis susceptibility-related RNA Gene Induced by Stress) was significantly up regulated in hypoxic conditions and had specific interaction with RANTES as confirmed through reporter assay. These observations show first evidence for RANTES produced by renal tubular cells act as a key chemokine in AKI and HIF-1α regulated LncRNA-PRINS might be involved in RANTES production.
Similar content being viewed by others
Introduction
Infiltration of leukocytes into ischemic tissues in kidney ischemia-reperfusion injury (IRI) has been associated with adverse outcomes of acute kidney injury (AKI)1,2. Following ischemic injury, rapid influx of circulating immune cells accompany with the release of several inflammatory molecules such as cytokines, chemokines and complement3. Chemokines and their receptors play a crucial role in the inflammatory responses which greatly enhances the recruitment of immune cells including neutrophils, monocytes and lymphocytes4,5. Several chemokines have been demonstrated to be involved in kidney inflammatory response in IRI. For example, IL-8/CXCL8, MIP-2/Gro-β/CXCL2 and Gro-α/CXCL1 are suggested to be associated with marked neutrophil infiltration after IRI and the CCL subfamily (MCP-1/CCL2) and CX3CL subfamily (fractalkine/CX3CL1) may have specific effects on monocytes and monocyte-derived lineages5. Therefore, chemokines has been suggested to play an important role in affecting the inflammatory reaction in IRI.
RANTES (Regulated on Activation Normal T cell Expressed and Secreted, also known as CCL5), a member of the CC-chemokine family, is well-known for its potent chemo-attractant effect on immune cells. It could be secreted by various tissues and has been shown to simultaneously orchestrate the recruitment of several immune cells, such as neutrophils, monocytes and lymphocytes4,5,6. An extensive level of RANTES on cell surfaces during IRI has shown to act as a powerful activator of leukocytes7. In many clinical situations, including atherosclerosis, stroke and myocardial IRI, RANTES has been demonstrated to play a dominant role in infiltrating inflammatory cells and concomitantly promotes the release of other inflammatory cytokines in the site of post-ischemia inflammatory injury7,8,9,10,11. RANTES participates in immune responses in myocardial infarction by recruiting neutrophils and monocytes thereby mediate cerebral ischemia7,10. However, data regarding the role of RANTES in ischemia kidney injury is not very well known.
Emerging evidence show long non coding RNAs (LncRNA’s) as key regulatory molecules in cellular signaling12. These RNAs contain nucleotides with size greater than 200 and functions in epigenetic regulation, transcriptional, post-transcriptional and translation events13. Aberrant expression of LncRNA’s has been implicated under various diseases12. However, important LncRNA involved in regulatory process of acute kidney injury has not been explored till date.
Given its patho physiological role in many diseases caused by ischemic reperfusion and its great capacity to recruit inflammatory cells, RANTES might be relevant to the inflammatory response in acute kidney injury following IRI. The aim of this study was to 1. Investigate the role of RANTES in post-ischemia inflammatory responses and its associated renal function changes in AKI. 2. To identify functional contribution of hypoxia and LncRNA in RANTES expression.
Results
RANTES expression increased in kidney IRI of wild type mice
To determine RANTES expression in kidney IRI, we performed immunohistochemical staining on days 1, 3 and 7 in wild type mice after kidney IRI. Sham operated controls did not show any RANTES expression. However, there was significant increase in RANTES expression in renal tubular epithelial cells on day 3 (P < 0.001) compared to sham mice (Fig. 1).
Renal function was better in RANTES(−/−) mice with IRI
To determine the renal function, serum creatinine was measured in wild type and RANTES(−/−) mice on days 1 and 7 post kidney IRI. Compared to wild mice, serum creatinine were significantly lower in the RANTES(−/−) mice on days 1 and 7 (P < 0.01) (Fig. 2).
Acute tubular necrosis decreased in the RANTES(−/−) mice with kidney IRI
To compare the tubular injury in RANTES(−/−) and wild-type mice with IRI, we examined the acute tubular necrosis (ATN) score by histopathology. In the wild-type mice, extensive tubular necrosis, loss of brush border, cast formation, tubular dilation and inflammatory infiltrates was noted at the cortico medullary junction after IRI. However, tubular damage was attenuated in the RANTES(−/−) mice and maintained normal kidney morphology (Fig. 3a). The results from ATN score demonstrate that the RANTES(−/−) mice had lower ATN score after IRI which was statistically significant (P < 0.01) when compared to wild-type mice (Fig. 3b). Sham operated mice had no tubular injuries (Data not shown).
Impaired infiltration of inflammatory cells after IRI in RANTES(−/−) mice
To investigate recruitment of inflammatory cell infiltrates in RANTES(−/−) mice, we performed immunohistochemisty to detect neutrophils, lymphocytes and macrophages on days 1, 3 and 7 after kidney IRI. A substantial number of interstitial cells accumulated in the cortical-medullary area of the wild-type mice in IRI. In addition, a significantly less infiltrating cells including Ly6G, CD3+, F4/80 (P < 0.01) were noted in the RANTES(−/−) mice compared with wild-type mice (Fig. 4).
Proinflammatory cytokines and chemokines production were attenuated in RANTES(−/−) mice with kidney IRI
To determine the inflammatory cytokines after IRI, we measured the mRNA expression of TNF-α, IL-1β and MCP-1 in the kidneys. An increase in TNF-α, IL-1β and MCP-1 on days 13 and 7 after IRI was found in wild mice compared to sham operated mice. However, a significant decrease (P < 0.05) in inflammatory cytokines expression were noted in the RANTES(−/−) mice compared to wild type mice (Fig. 5a–c).
NF-κB-p50 regulates RANTES expression
In order to determine hypoxia-induced RANTES expression, cultured renal tubular cells were exposed to hypoxic stress for 6 and 16 hours. Western blot results showed significant up regulation in CCL5/RANTES expression at 6 (P < 0.05) and 16 hours (P < 0.01) compared to control (Fig. 6a). Figure 6b shows pre-treatment with NF-κB inhibitor followed by hypoxic stress, significantly down regulated RANTES expression at 6 and 16 hours (P < 0.05) compared to control. Figure 6c demonstrates NF-κB activation under hypoxic condition through EMSA. There was increase in NF-κB-DNA binding activity in renal tubular cells under hypoxia for 6 hours.
HIF-1α regulates LncRNA expression in hypoxic renal tubular cells
In order to identify whether LncRNAs are involved in AKI, we first determined hypoxia responsive LncRNA expression in HK-2- wild type and sh-HIF-1α knockdown cells using Q-PCR based Disease Related Lnc-RNA array (Systems Biosciences). Figure 7a shows deregulated LncRNAs in wild type HK-2 cells under 24 hours hypoxia/normoxia. The results reveal that hypoxia induced differential expression of LncRNAs; 28 LncRNAs up regulated (>1 fold) and 55 LncRNAs down regulated ( < 1 fold). Among the up regulated Lnc-RNAs, 7 were increased with >2 fold, WT-1AS (~150), DLG2AS1 (~40), PRINS (~6), HOTAIRMI (~5), EGO (~3), TU 0017629 and I1pa16 (~2). Figure 7b shows Lnc-RNA expression in HK-2- sh HIF-1α cells/wild type under hypoxia. Among the deregulated LncRNAs, 41 were up regulated (>1 fold) and 42 were down regulated ( < 1 fold). For determining HIF-1α dependent LncRNAs, the up regulated LncRNAs under hypoxia were analyzed for their regulation in sh HIF-1α cells. Figure 7c, shows hypoxia responsive LncRNAs and their down regulated position in HIF-1α knockdown cells.
We next attempted to identify whether HIF-1α dependent LncRNAs are involved in RANTES regulation, for this their binding potential with RANTES was determined through bioinformatics analysis14. The results show that among the LncRNAs, DLG2AS1 and PRINS had sequence homology with RANTES (Fig. 7c). These results highlight that DLG2AS1 and PRINS as HIF-1α regulated LncRNA which might interact with RANTES under hypoxia.
LncRNA PRINS (Psoriasis susceptibility-related RNA Gene Induced by Stress) interacts with RANTES under hypoxia
To investigate whether DLG2AS1 and PRINS have any functional role in RANTES regulation, the mRNA expression of RANTES and LncRNA (DLG2AS1 and PRINS) transcripts were analyzed through Q-PCR analysis. Time course study (3, 6, 16, 24 and 48 hr) showed significant increase (P < 0.001) in RANTES mRNA expression at 3 hr and 6 hr hypoxia compared to normoxia (Fig. 7d). Further, expression of DLG2AS1 and PRINS transcripts were determined at this time point. A significant up regulation of PRINS (P < 0.001) and RANTES expression (P < 0.01) appeared under hypoxic condition compared to normoxia (Fig. 7e). However, LncRNA- DLG2AS expression was not significantly regulated (Data not shown). Further, to validate interaction between LncRNA-PRINS and RANTES reporter assay was performed. For this we constructed the specific RANTES sequence having LncRNA-PRINS interacting site in pmir-GLO dual luciferase reporter at the 3′ end of firefly luciferase coding sequence. Reporter assay showed significant repression (P < 0.001) of luciferase activity at 6 hr hypoxia (Fig. 7f). Together these observations demonstrate that both LncRNA-PRINS and RANTES are significantly up regulated and interact under hypoxic condition.
Discussion
Ischemic reperfusion injury aggravates acute kidney injury (AKI)15,16,17,18 and several inflammatory mediators are known to involve in AKI5,19,20,21,22. RANTES is one of the inflammatory mediators involved in IRI-related diseases through its potent chemo-attractant effect and for its great capacity to recruit immune cells which results in significant inflammatory injury. However, the role of RANTES in acute kidney injury remains elusive. In the present study, we found that RANTES obviously increased in renal tubular cells which further aggravated kidney injury through recruiting inflammatory cells and leading to loss of renal function after IRI in wild type mice. Genetically deficient RANTES mice (RANTES(−/−)) showed better renal function by significant down regulation of RANTES expression with impairment in recruitment of inflammatory cells and production of cytokines and chemokines post kidney IRI. In addition, we found that HIF-1α as a key LncRNA regulator in renal tubular cells and show that HIF-1α responsive LncRNA-PRINS might regulate RANTES production and involve in AKI process.
The influence of RANTES has been demonstrated in several ischemic organ diseases. RANTES was found to contribute in cardiac dysfunction and heart failure in mice myocardial reperfusion injury model10. As in mice with brain infarction, a significantly decreased infarction area was observed in brain tissue of RANTES-deficient mice7. Studies on ischemic injury in arterial vessels show that local vascular smooth muscle cells (SMC) play an active role in RANTES production and involve in T-lymphocyte infiltration, which consequently aggravates arterial injury in IRI9,23. To evaluate the role of RANTES in kidney IRI, we performed the study in RANTES(−/−) mice and compared the effects with that of wild type mice. We observed up regulation of RANTES expression in renal tubular cells of wild type mice throughout the study schedule post IRI on days 1, 3 and 7. A significant increase in RANTES expression on day 3 might be linked to late response of renal tubular cells during ischemic injury. Although the effect of RANTES has been determined in other kidney diseases, such as acute rejection, chronic glomerulonephritis or chronic kidney failure24, our study is the first to demonstrate the influence of RANTES in AKI. In addition, RANTES(−/−) mice showed significant attenuation of AKI with less acute tubular necrosis and lower serum creatinine levels compared to wild-type mice.
RANTES contributes to IRI through enhancing various inflammatory responses by recruiting immune cells through cognate receptors CCR1 and CCR54,19,20. Treatment with RANTES antagonists reduced tissue damage in IRI-related diseases such as myocardial infarction or brain infarction by significant decrease in infiltrating inflammatory cells, such as neutrophils, macrophages and lymphocytes7,10. In the current study, RANTES(−/−) mice showed impaired recruitment of inflammatory cells such as neutrophils (Ly6G), lymphocytes (CD3+) and macrophages (F4/80) in kidney after IRI compared to wild-type mice. Our data suggests that the chemotactic effect of RANTES influences the infiltrating cells throughout the course of kidney IRI. In a recent study, Ko et al. found that infiltrating T cells with simultaneous over expression of CCR5 in kidney IRI was highly associated with AKI, such effect was alleviated by blocking CCR520. It has been well recognized that CCR5 is the major cellular receptor for RANTES in monocytes; therefore, deficiency of RANTES in renal tubular cells significantly reduced cellular infiltration in kidney IRI. Although previous studies suggested that T lymphocytes are the principal effector cells for the RANTES effect, the present study showed interesting finding on contribution of other infiltrating inflammatory cells (neutrophils and macrophages) in RANTES mediated cellular infiltration in kidney IRI. We supposed that in complex post-ischemia inflammatory reaction absence of RANTES affected participation of classic chemo attractants, which highlights the crucial role of RANTES in kidney IRI.
In addition, RANTES has been assumed to orchestrate inflammatory cytokines production during the post-ischemia inflammatory response in IRI. RANTES(−/−) mice or mice treated with anti-RANTES mAb showed significant reduction in inflammatory cytokines including IL-6, IL-10, TNF-α, MCP-I in IRI diseases, such as myocardial ischemia, stroke and hypoxia-related apnea syndrome10,7,9. In our study, the qPCR data revealed that pro-inflammatory cytokines including TNF-α, IL-1β and MCP-1 (CCL2) decreased significantly on days 3 and 7 in the RANTES(−/−) mice. Of note, the level of MCP-1 as well as that of other cytokines significantly decreased on day 7 in the RANTES(−/−) mice compared to the wild-type mice. A more profound decrease in the inflammatory responses with associated less renal injury observed in the RANTES(−/−) mice than in the wild-type mice. The present study observations were consistent with previous studies using RANTES blockers9,10,25. Taken together, we suggest that the expression of RANTES in renal tubular epithelial cells indicates a cellular inflammatory response between tubular endothelial cells and infiltrating leukocytes through releasing multiple inflammatory mediators that results in an overwhelming immunological injury in kidney IRI.
Accumulating evidence suggests that RANTES expression is highly associated with NF-κB signaling and both of them act coordinately to influence inflammatory cell recruitment in several inflammatory diseases. Studies show that RANTES expression is dependent on NF-κB activation by their subsequent binding to the RANTES promoter9,23. RANTES production in vascular SMC critically depends on the NF-κB signaling pathway in ischemic vascular injury and hypoxic artery remodeling9. To explore whether the NF-κB signaling pathway is involved in RANTES production in renal tubular cells, a hypoxic in vitro study was performed. The study showed increased NF-κB-p50 DNA binding at 6 hours post hypoxic stress with increased CCL5/RANTES expression at 16 hours. In addition, the expression of RANTES was significantly decreased when renal tubular cells were treated with NF-κB inhibitor under hypoxia. Our findings suggest that NF-κB is associated with the production of RANTES in renal tubular cells suffering from hypoxia.
Emerging reports show that long non-coding transcripts (LncRNAs) regulate protein coding genes in human diseases26. To date hypoxia regulated long non-coding transcripts have been largely identified in various cancers. Takahashi et al. (2014) demonstrated that hypoxia responsive LncRNA-ROR promotes cell survival in HCC cells27. Yang et al. found that down regulation of LncRNA-LET has been associated in hypoxia-induced cellular invasion in hepatic cancer28. Little is known regarding LncRNAs in ischemic injury. Previous studies show deregulated LncRNA’s in focal ischemia and regulatory function of AK139328 in liver ischemia/reperfusion injury29,30. Recent study by Lorenzen et al. (2015) showed that circulating levels of LncRNA- TapSaki as a major predictor of mortality in AKI patients31. However, the importance of LncRNAs in relation to AKI process is unknown. Here we report firstly that, renal tubular cells differentially express LncRNA’s under hypoxic conditions and among the 83 disease related LncRNAs, 28 LncRNAs were up regulated and 55 LncRNAs were down regulated.
HIF is a major regulatory protein in hypoxia-induced pathogenesis; here we identified that PRINS as HIF-1α dependent LncRNA and PRINS was significantly up regulated throughout the hypoxic conditions. Previous reports show that, PRINS as a stress induced LncRNA which regulates apoptosis and functionally contributes in psoriasis susceptibility32,33. Studies also support that HIF as a key LncRNA regulator in cancer development. A study conducted by Choudhry et al. show that HIF-2α dependent transcriptional activation of NEAT1 contributes to breast cancer tumorigenesis34. Further, HIF-1α-responsive lincRNA-p21 and lncRNA-UCA1 is crucial to hypoxia-enhanced glycolysis35 and bladder cancer progression36 respectively.
Recent reports on LncRNAs provide evidence for their role in cytokine regulation. LincRNA1992 -THRIL is highly associated with Kawasaki disease and regulates immune responses through TNF-α37. TH2-LCR LncRNA induces TH-lineage specific cytokines IL-4, IL-5 and IL-13 and regulates T-helper cell differentiation38. Lnc-IL7R is involved in the early immune response through regulation of E-selectin, VCAM-1, IL-8 and IL-6 expression39. LncRNA- AK139328 knockdown ameliorates liver ischemia/reperfusion injury by reducing inflammatory cytokines30. We in the present study demonstrate that LncRNA-PRINS had specific interaction with RANTES and both were significantly up regulated under hypoxic conditions. Further, we provide evidence that HIF-1α is the important mediator in RANTES production through LncRNA regulation. Together, we present for the first time a link between HIF-1α responsive LncRNA in cytokine regulation. However, exact mechanism has to be elucidated; nevertheless these findings provide novel evidence for HIF-1α regulated PRINS in RANTES regulation.
In conclusion, the study demonstrates RANTES as a crucial mediator in acute kidney injury following IR. RANTES mediates AKI through post-ischemia inflammatory reaction constituting ischemic renal tubular cells, infiltrating leukocytes and pro-inflammatory cytokines. Further, RANTES expression is regulated by NF-κB and PRINS might act as a HIF-1α dependent LncRNA and involve in the process of AKI. Thus, HIF-1α-LncRNA-PRINS-RANTES axis might play a regulatory role in AKI.
Materials and Methods
Experimental Animals and Protocol
Male wild-type C57BL/6C (B6) mice were purchased from BioLASCO Taiwan Co, Ltd (Taipei, Taiwan) and RANTES−/− mice were obtained from the Jackson Laboratory (Bar Harbor, ME, USA); their background has been described previously40. The mice were maintained under specific pathogen-free housing conditions in China Medical University. Male mice aged 6-8 weeks and weighing 15–20 g were used in the experiments. All animal procedures were approved by Animal Ethics Committee of China Medical University (CMU-101-100-N) and carried out in accordance with the guidelines of Animal Care and Use Guidelines of the China Medical University. The procedure used to induce kidney IRI in the experiments has been described previously41. In brief, the mice were anesthetized with ketamine (100 mg/kg intraperitoneally), xylazine (10 mg/kg intraperitoneally) and acepromazine (1 mg/kg intramuscularly) and then subjected to a midline abdominal incision. After general anesthesia, both renal pedicles were clamped for 35 minutes with microaneurysm clamps. After removal of the clamps, the kidneys were observed for 1 minute for restoration of blood flow. Kidneys that did not return to their original color after unclamping were not used for analysis. During the procedure, warm saline was instilled into the peritoneal cavity. Abdominal wounds were closed and examined daily and animals with signs of wound infection or dehiscence were excluded from the study. All mice were returned to individual ventilated cages with free access to food and water. Sham surgery was performed using the same experimental procedures, except that the renal vessels were not clamped. The mice were sacrificed 1, 3 and 7 days after reperfusion.
Histology Examination
Histology was performed and all the groups were analyzed for tubular injury.
Assessment of Renal Function
Serum creatinine was measured using an Astra Auto analyzer (Beckman Instruments, Fullerton, CA).
Immunohistochemistry (IHC) Staining
Immumohistochemical staining was performed to detect the expression of RANTES, neutrophils (Ly6G), lymphocytes (CD3+) and macrophages (F4/80).
Quantitative real-time PCR
Total RNA was isolated, cDNA was synthesized and qPCR was performed using a RealTime ready assay (TNF-α, IL-1β, MCP-1, GAPDH), with the gene expression analysis done using a Universal ProbeLibrary System on a LightCycler® 480 System (Roche). LncRNA expression (PRINS and DLG2AS1) were analyzed using TaqMan® Non-coding RNA Assays (Life technologies).
Western blot
Western blot was performed to analyze the expression of RANTES.
Nuclear Extraction and Electrophoretic Mobility Shift Assay (EMSA)
NF-κB DNA binding activity was measured by EMSA.
shRNA HIF- 1α knockdown by viral infection
HK-2 were infected with lentivirus expressing shRNA for HIF-1α in the presence of 8 μg/ml protamine sulfate for 24 h, followed by puromycin (2 μg/ml; 48 h) selection. shLacZ which targets the LacZ gene, was used as a control. The knockdown efficiency of HIF-1α was examined using Q-PCR (Biometra T1 thermo cycler).
LncRNA profiling
Differentially expressed Lnc-RNAs in HK-2 cells and sh-HIF-1α HK-2 cells were identified using Human Disease-Related LncRNA Profiler (CAT# RA920D, System Biosciences).
Dual-luciferase reporter assay
The HK-2 cells were transfected with 1μg of PRINS vector or control vector for 24 hours and exposed to normoxia/hypoxic conditions. After treatment, the cells were harvested, lysed and assay was carried out as per manufacturer’s protocol (Dual-Luciferase Reporter Assay System, Promega, Madison, WI).
Statistical analysis
All the data are expressed as mean ± SD unless otherwise specified. Comparisons among multiple groups were performed using 1- or 2-way ANOVA. Statistical differences between 2 groups were calculated using an unpaired Student’s t test (2-tailed). P values less than 0.05, 0.01, 0.001 were considered significant.
Additional Information
How to cite this article: Yu, T.-M. et al. RANTES mediates kidney ischemia reperfusion injury through a possible role of HIF-1a and LncRNA PRINS. Sci. Rep. 6, 18424; doi: 10.1038/srep18424 (2016).
References
Bonventre, J. V. & Yang, L. Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Invest. 121, 4210–4221 (2011).
Devarajan, P. Update on mechanisms of ischemic acute kidney injury. J. Am. Soc. Nephrol. 17, 1503–1520 (2006).
Eltzschig, H. K. & Eckle, T. Ischemia and reperfusion-from mechanism to translation. Nat. Med. 17, 1391–1401 (2011).
Charo, I. F. & Ransohoff, R. M. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354, 610–621 (2006).
Chung, A. C. & Lan, H. Y. Chemokines in renal injury. J. Am. Soc. Nephrol. 22, 802–809 (2011).
Krensky, A. M. & Ahn, Y. T. Mechanisms of disease: regulation of RANTES (CCL5) in renal disease. Nat. Clin. Pract. Nephrol. 3, 164–170 (2007).
Terao, S. et al. Blood cell-derived RANTES mediates cerebral microvascular dysfunction, inflammation and tissue injury after focal ischemia-reperfusion. Stroke. 39, 2560–2570 (2008).
Rodrigues, S. F. & Granger, D. N. Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure. Cardiovasc. Res. 87, 291–299 (2010).
Arnaud, C. et al. The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition. Am. J. Respir. Crit. Care. Med. 184, 724–731 (2011).
Montecucco, F. et al. CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice. Eur. Heart. J. 33, 1964–1974 (2012).
Shahrara, S. et al. Amelioration of rat adjuvant-induced arthritis by Met-RANTES. Arthritis. Rheum. 52, 1907–1919 (2005).
Mercer, T. R., Dinger, M. E. & Mattick, J. S. Long non-coding RNAs: Insights into functions. Nat. Rev. Genet. 10, 155–159 (2009).
Mercer, T. R. & Mattick, J. S. Structure and function of long noncoding RNAs in epigenetic regulation. Nat. Struct. Mol. Biol. 20, 300–307 (2013).
Wright, P. R. et al. CopraRNA and IntaRNA: predicting small RNA targets, networks and interaction domains. Nucleic. Acids. Res. 42, (Web Server issue) W119–W123 (2014).
Rabb, H. et al. Pathophysiological role of T lymphocytes in renal ischemia-reperfusion injury in mice. Am. J. Physiol. Renal. Physiol. 279, F525–F531 (2000).
Rabb, H. The T cell as a bridge between innate and adaptive immune systems: implications for the kidney. Kidney. Int. 61, 1935–1946 (2002).
Ysebaert, D. K. et al. T cells as mediators in renal ischemia/reperfusion injury. Kidney. Int. 66, 491–496 (2004).
Savransky, V. et al. Role of the T-cell receptor in kidney ischemia-reperfusion injury. Kidney. Int. 69, 233–238 (2006).
Furuichi, K. et al. Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury. J. Immunol. 181, 8670–8676 (2008).
Ko, G. J. et al. Transcriptional analysis of infiltrating T cells in kidney ischemia-reperfusion injury reveals a pathophysiological role for CCR5. Am. J. Physiol. Renal Physiol. 302, F762–F773 (2012).
Schober, A. Chemokines in vascular dysfunction and remodeling. Arterioscler. Thromb. Vasc. Biol. 28, 1950–1959 (2008).
Oh, D. J. et al. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice. Am. J. Physiol. Renal. Physiol. 294, F264–F271 (2008).
Kovacic, J. C. et al. Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice. J. Clin. Invest. 120, 303–314 (2010).
Segerer, S., Nelson, P. J. & Schlondorff, D. Chemokines, chemokine receptors and renal disease: from basic science to pathophysiologic and therapeutic studies. J. Am. Soc. Nephrol. 11, 152–176 (2000).
Koenen, R. R. et al. Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat. Med. 15, 97–103 (2009).
Wapinski, O. & Chang, H. Y. Long noncoding RNAs and human disease. Trends. Cell. Biol. 21, 354–361 (2011).
Takahashi, K., Yan, I. K., Haga, H. & Patel T. Modulation of hypoxia-signaling pathways by extracellular linc-RoR. J. Cell. Sci. 127, 1585–1594 (2014).
Yang, F. et al. Repression of the long noncoding RNA-LET by histone deacetylase 3 contributes to hypoxia-mediated metastasis. Mol. Cell 49, 1083–1096 (2013).
Dharap, A., Nakka, V. P. & Vemuganti, R. Effect of focal ischemia on long noncoding RNAs. Stroke. 43, 2800–2802 (2012).
Chen, Z. et al. Silencing of Long Noncoding RNA AK139328 Attenuates Ischemia/Reperfusion Injury in Mouse Livers. PLoS ONE. 8, e80817 (2013).
Lorenzen, J. M. et al. Circulating long noncoding RNATapSaki is a predictor of mortality in critically ill patients with acute kidney injury. Clin. Chem. 61, 191–201 (2015).
Sonkoly, E. et al. Identification and characterization of a novel, psoriasis susceptibility-related noncoding RNA gene, PRINS. J. Biol. Chem. 280, 24159–24167 (2005).
Szegedi, K. et al. The anti-apoptotic protein G1P3 is over expressed in psoriasis and regulated by the non-coding RNA, PRINS. Exp. Dermatol. 19, 269–278 (2010).
Choudhry, H. et al. Tumor hypoxia induces nuclear paraspeckle formation through HIF-2α dependent transcriptional activation of NEAT1 leading to cancer cell survival. Oncogene. 34, 4482–4490 (2015).
Yang, F., Zhang, H., Mei, Y. & Wu, M. Reciprocal regulation of HIF-1alpha and lincRNAp21 modulates the Warburg effect. Mol. Cell. 53, 88–100 (2014).
Xue, M., Li, X., Li, Z. & Chen, W. Urothelial carcinoma associated 1 is a hypoxia-inducible factor-1alpha-targeted long noncoding RNA that enhances hypoxic bladder cancer cell proliferation, migration and invasion. Tumour. Biol. 35, 6901–6912 (2014).
Li, Z. et al. The long noncoding RNA THRIL regulates TNFα expression through its interaction with hnRNPL. Proc. Natl. Acad. Sci. USA 111, 1002–1007 (2014).
Spurlock, C. F. et al. Expression and functions of long noncoding RNAs during human T helper cell differentiation. Nat. Commun. 6, 6932 (2015).
Cui, H. et al. The human long noncoding RNA, lnc-IL7R, regulates inflammatory response. Eur. J. Immunol. 44, 2085–2295 (2014).
Liou, J. T., Yuan, H. B., Mao, C. C., Lai, Y. S. & Day, Y. J. Absence of C-C motif chemokine ligand 5 in mice leads to decreased local macrophage recruitment and behavioral hypersensitivity in a murine neuropathic pain model. Pain. 153, 1283–1291 (2012).
Day, Y. J. et al. Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells. J. Clin. Invest. 112, 883–891 (2003).
Chien, C. H. et al. Identifying transcriptional start sites of human microRNAs based on high-throughput sequencing data. Nucleic. Acids. Res. 39, 9345–9356 (2011).
Acknowledgements
The study was supported in part by the National Science Council, Executive Yuan, Taiwan (Grant number: NSC-101-2314-B-039-004-MY3), China Medical University Hospital (Grant number: DMR-100-052, DMR-101-005, DMR-102-040, DMR-103-069), Research Laboratory of Pediatrics, Children’s Hospital of China Medical University, Taiwan and Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (Grant number: MOHW 104-TDU-B-212-113002).
Author information
Authors and Affiliations
Contributions
T.Y. and K.P. - Conceived and/or designed the work that led to the submission, acquired data, and/or played an important role in interpreting the results. Drafted or revised the manuscript. K.S., Y.D., K.S., I.W., W.S., P.C. and Y.C. - Drafted or revised the manuscript. C.L.- Conceived and/or designed the work that led to the submission, acquired data, and/or played an important role in interpreting the results. Approved the final version.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Electronic supplementary material
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Yu, TM., Palanisamy, K., Sun, KT. et al. RANTES mediates kidney ischemia reperfusion injury through a possible role of HIF-1α and LncRNA PRINS. Sci Rep 6, 18424 (2016). https://doi.org/10.1038/srep18424
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/srep18424
This article is cited by
-
Role of the Neanderthal Genome in Genetic Susceptibility to COVID-19: 3p21.31 Locus in the Spotlight
Biochemical Genetics (2024)
-
CircPTP4A2 Promotes Microglia Polarization in Cerebral Ischemic Stroke via miR-20b-5p/YTHDF1/TIMP2 Axis
NeuroMolecular Medicine (2023)
-
LncRNA IRAR regulates chemokines production in tubular epithelial cells thus promoting kidney ischemia-reperfusion injury
Cell Death & Disease (2022)
-
Divergent regulation of lncRNA expression by ischemia in adult and aging mice
GeroScience (2022)
-
An in-silico method leads to recognition of hub genes and crucial pathways in survival of patients with breast cancer
Scientific Reports (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.